The current status of antiparasite chemotherapy

Parasitology

Volumn 114, Issue SUPPL. 1, 1997, Pages

  Croft, S L ^a  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

5 NITROIMIDAZOLE DERIVATIVE; ALBENDAZOLE; AMPHOTERICIN B LIPID COMPLEX; ARTEFLENE; ARTEMETHER; ARTEMISININ; ARTESUNATE; ATOVAQUONE; BENZIMIDAZOLE DERIVATIVE; BUPARVAQUONE; DIMINAZENE ACETURATE; EFLORNITHINE; FANSIDAR; IVERMECTIN; LASALOCID; MACROLIDE; MEBENDAZOLE; METRONIDAZOLE; MILBEMYCIN; MONENSIN; PAMAQUINE; PARVAQUONE; POLYENE ANTIBIOTIC AGENT; PRAZIQUANTEL; PRIMAQUINE; SALINOMYCIN; SESQUITERPENE DERIVATIVE; TIABENDAZOLE; TINIDAZOLE; UNCLASSIFIED DRUG; WR 279138;

ANTHELMINTIC ACTIVITY; CONFERENCE PAPER; DRUG BIOAVAILABILITY; DRUG EFFICACY; FILARIASIS; HELMINTHIASIS; HUMAN; LEISHMANIASIS; MALARIA; MALARIA FALCIPARUM; MICROSPORIDIOSIS; NONHUMAN; PRIORITY JOURNAL; PROPHYLAXIS; PROTOZOAL INFECTION; TRYPANOSOMIASIS;

ANIMALS; ANTHELMINTICS; ANTIPARASITIC AGENTS; ANTIPROTOZOAL AGENTS; COCCIDIOSIS; DRUG DESIGN; DRUG INDUSTRY; HELMINTHIASIS; MASTIGOPHORA INFECTIONS; MICROSPORIDIOSIS;

ARTESUNATE;

EID: 0030883946     PISSN: 00311820     EISSN: None     Source Type: Journal    
DOI: 10.1017/s0031182097001182     Document Type: Article

References (89)

1. ABDI, Y., GUSTAFSSON, L. L., ERICSSON, O. & HELLGREN, U. (1995). Handbook of Drugs for Tropical Parasitic Infections. London: Taylor & Francis.
2. ANON (1993). Drugs for parasitic infections. The Medical Letter on Drugs and Therapeutics 35, 111-122.
3. BAUMANN, R. J., MCCANN, P. P. & BITONTI, A. J. (1991). Suppression of Leishmania donovani by oral administration of a bis(benzyl) polyamine analog. Antimicrobial Agents and Chemotherapy 35, 1403-1407.
4. BISSUEL, F., COTTE, L., RABODONIRINA, M., ROUGIER, P., PIENS, M-A. & TREPO, C. (1994). Paromomycin: an effective treatment for cryptosporidial diarrhea in patients with AIDS. Clinical Infectious Diseases 18, 447-449.
5. BLANCHARD, T. J., MABEY, D. C. W., HUNT-COOKE, A., EDWARDS, G., HUTCHINSON, D. B. A., BENJAMIN, S. & CHIODINI, P. L. (1994). Multiresistant falciparum malaria cured using atovaquone and proguanil. Transactions of the Royal Society of Tropical Medicine and Hygiene 88, 693.
6. BLONDELLE, S. E., PÉREZ-PAYÁ, & HOUGHTEN, R. A. (1996). Synthetic combinatorial libraries: novel discovery strategy for identification of antimicrobial agents. Antimicrobial Agents and Chemotherapy 40, 1067-1071.
7. BOOTH, R. G., SELASSIE, C. D., HANSCH, C. & SANTI, D. V. (1987). Quantitative structure-activity relationship of triazine-antifolate inhibition of Leishmania dihydrofolate reductase and cell growth. Journal of Medicinal Chemistry 30, 1218-1224.
8. BRENER, Z., CANÇADO, J. R., DA CUNHA GALVAO, L. M., PROFETA DA LUZ, Z. M., DE SOUSA FILARDI, L., SOARES PEREIRA, M. E., SANTOS, L. M. T. & CANÇADO, C. B. (1993). An experimental and clinical assay with ketoconazole in the treatment of Chagas disease. Memorias do Instituto Oswaldo Cruz 88, 149-153.
9. BRINDLEY, P. J. (1994). Drug resistance to schistosomicides and other anthelmintics of medical significance. Acta Tropica 56, 213-231.
10. BUNDY, D. A. P. & GUYATT, H. L. (1995). Anthelmintic chemotherapy: the individual and the community. Current Opinions in Infectious Diseases 8, 466-472.
11. BURRI, C., BLUM, J. & BRUN, R. (1995). Alternative application of melarsoprol for treatment of T. b. gambiense sleeping sickness. Annales de la Société Belge de Médecine Tropicale 75, 65-71.
12. CAMPBELL, W. C. (1990). Benzimidazoles: veterinary uses. Parasitology Today 6, 130-133.
13. CAMPBELL, W. C. & REW, R. S. (Editors) (1986). Chemotherapy of Parasitic Diseases. New York: Plenum Press.
14. CANFIELD, C. J., PUDNEY, M. & GUTTERIDGE, W. C. (1995). Interactions of atovaquone with other antimalarial drugs against Plasmodium falciparum in vitro. Experimental Parasitology 80, 373-381.
15. CARTER, N. S., BERGER, B. J. & FAIRLAMB, A. H. (1995). Uptake of diamidine drugs by the P2 nucleoside transporter in melarsen-sensitive and -resistant Trypanosoma brucei brucei. Journal of Biological Chemistry 270, 28153-28157.
16. CHAVASSE, D. C., POST, R. J., DAVIES, J. B. & WHITWORTH, J. A. G. (1993). Absence of sperm from the seminal receptacle of female Onchocerca volvulus following multiple doses of Ivermectin. Tropical Medicine and Parasitology 44, 155-158.
17. CIOLI, D., PICA-MATTOCCIA, L. & ARCHER, S. (1995). Antischistosomal drugs: past, present . . . and future? Pharmacology and Therapeutics 68, 35-85.
18. CLINE, B. L., HERNANDEZ, J. L., MATHER, F. J., BARTHOLOMEW, R., NUNEZ DE MAZA, S., RODULFO, S., WELBORN, C. A., EBERHARD, M. L. & CONVIT, J. (1992). Albendazole in the treatment of onchocerciasis: double-blind clinical trial in Venezuela. American Journal of Tropical Medicine and Hygiene 47, 512-520.
19. CLINTON WHITE JR., A., CHAPPELL, C. L., SIKANDER HAYAT, C., KIMBALL, K. T., FLANIGAN, T. P. & GOODGAME, R. W. (19994). Paromomycin for cryptosporidiosis in AIDS: a prospective, double-blind trial. Journal of Infectious Diseases 170, 419-424.
20. COHEN, S. S. (1979). Comparative biochemistry and drug design for infectious disease. Science 205, 964-971.
21. COLLINS, W. E. & JEFFERY, G. M. (1996). Primaquine resistance in Plasmodium vivax. American Journal of Tropical Medicine and Hygiene 55, 243-249.
22. COOK, G. C. (1990). Use of benzimidazole chemotherapy in human helminthiases: indications and efficacy. Parasitology Today 6, 133-136.
23. DALTRY, A., HILMARSDOTTIR, I., MAYORGA-SAGASTUME, R., LYAGOUBI, M., GAXOTTE, P., BILIGUI, S., CHODAKEWITZ, J., NEU, D., DANIS, M. & GENTILINI, M. (1994). Treatment of Strongyloides stercoralis infection with Ivermectin compared with Albendazole: results of an open study of 60 cases. Transactions of the Royal Society of Tropical Medicine and Hygiene 88, 344-345.
24. DAVIDSON, R. N., DI MARTINO, L., GRADONI, L., GIACCHINO, R., GAETA, G. B., PEMPINELLO, R., SCOTTI, S., CASCIO, A., CASTAGNOLA, E., MAISTO, A., GRAMICCIA, M., DI CAPRIO, D., WILKINSON, R. J. & BRYCESON, A. D. M. (1996). Short-course treatment of visceral leishmaniasis with liposomal Amphotericin B (AmBisome). Clinical Infectious Diseases 22, 938-943.
25. DE CASTRO, S. L. (1993). The challenge of Chagas' disease chemotherapy: an update of drugs assayed against Trypanosoma cruzi. Acta Tropica 53, 83-98.
26. DIDIER, E. S., ROGERS, L. B., BRUSH, A. D., WONG, S., TRAINA-DORGE, V. & BERTUCCI, D. (1996). Diagnosis of disseminated microsporidian Encephalitozoon hellem infection PCR-Southern analysis and successful treatment with albendazole and fumagillin. Journal of Clinical Microbiology 34, 947-952.
27. EDLIND, T. D. (1991). Protein synthesis as a target for antiprotozoal drugs. In Biochemical Protozoology (ed. Coombs, G. & North, M.), pp. 569-586. London: Taylor & Francis.
28. EHRLICH, P. (1913). Chemotherapeutics: scientific principles, methods and results. Lancet ii, 445-451.
29. ELFORD, B. C., COWAN, G. M. & FERGUSON, D. J. P. (1995). Parasite-regulated membrane transport processes and metabolic control in malaria-infected erythrocytes. Biochemical Journal 308, 361-374.
30. EL-ON, J., HALVEY, S., GRUNWALD, M. H. & WEINRAUCH, L. (1992). Topical treatment of Old World cutaneous leishmaniasis caused by Leishmania major - a double-blind study. Journal of the American Academy of Dermatology 27, 227-231.
31. FALLON, P. G., TAO, L-F., ISMAIL, M. M. & BENNETT, J. L. (1996). Schistosome resistance to praziquantel: fact or artifact? Parasitology Today 12, 316-320.
32. FERGUSON, D. J. P., HUSKINSON-MARK, J., ARAUJO, F. G. & REMINGTON, J. S. (1994). An ultrastructural study of the effect of treatment with atovaquone in brains of mice chronically infected with the ME49 strain of Toxoplasma gondii. International Journal of Experimental Pathology 75, 111-116.
33. GANN, P. H., NEVA, F. A. & GAM, A. A. (1994). A randomized trial of single and two-dose ivermectin versus thiabendazole for treatment of strongyloidiasis. Journal of Infectious Diseases 169, 1076-1079.
34. GINGER, C. (1991). Possibilities for new antiprotozoal drugs: the TDR/WHO approach. In Biochemical Protozoology (ed. Coombs, G. & North, M.), pp. 605-621. London: Taylor & Francis.
35. GUMBLETON, M. & SNEADER, W. (1994). Pharmacokinetic considerations in rational drug design. Clinical Pharmacokinetics 26, 161-168.
36. HABERKORN, A. (1996). Chemotherapy of human and animal coccidioses: state and perspectives. Parasitology Research 82, 193-199.
37. HIEN, T. T. & WHITE, N. J. (1993). Qinghaosu. Lancet 341, 603-608.
38. HOEPELMAN, A. I. M. (1996). Current therapeutic approaches to cryptosporidiosis in immunocompromised patients. Journal of Antimicrobial Chemotherapy 37, 871-880.
39. HOFSTENGE, J., CAPUANO, A., ALTSZULER, R. & MOORE, S. (1986). Carrier-linked primaquine in the chemotherapy of malaria. Journal of Medicinal Chemistry 29, 1765-1769.
40. HUDSON, A. T. (1993). Atovaquone - a novel broad-spectrum anti-infective drug. Parasitology Today 9, 66-68.
41. HUTT, A. J. & O'GRADY, J. O. (1996). Drug chirality: a consideration of the significance of the stereochemistry of antimicrobial agents. Journal of Antimicrobial Chemotherapy 37, 7-32.
42. ITEN, M., MATOVU, R., BRUN, R. & KAMINSKY, R. (1995). Innate lack of susceptibility of Ugandan Trypanosoma brucei rhodesiense to DL-α-difluoromethylornithine (DFMO). Tropical Medicine and Parasitology 46, 190-194.
43. KARLE, J. M., KARLE, I. L., GERENA, L. & MILHOUS, W. K. (1992). Stereochemical evaluation of the relative activities of the cinchona alkaloids against Plasmodium falciparum. Antimicrobial Agents and Chemotherapy 36, 1538-1544.
44. KATIYAR, S. K. & EDLIND, T. D. (1991). Enhanced antiparasitic activity of lipophilic tetracyclines: role of uptake. Antimicrobial Agents and Chemotherapy 35, 2198-2202.
45. KOVACS, J. A. (1992). Efficacy of atovaquone on treatment of toxoplasmosis in patients with AIDS. Lancet 340, 637-638.
46. KUZOE, F. A. S. (1993). Current situation of African trypanosomiasis. Acta Tropica 54, 153-162.
47. LACEY, E. & GILL, J. H. (1994). Biochemistry of benzimidazole resistance. Acta Tropica 56, 245-262.
48. LECUIT, M., OKSENHENDLER, E. & SARFATI, C. (1994). Use of albendazole for disseminated microsporidian infection in a patient with AIDS. Clinical Infectious Diseases 19, 332-333.
49. LOOAREESUWAN, S. (1994). Overview of clinical studies on artemisinin derivatives in Thailand. Transactions of the Royal Society of Tropical Medicine and Hygiene 88 (Suppl. 1), 9-11.
50. MCKELLAR, Q. A. (1994). Chemotherapy and delivery systems - helminths. Veterinary Parasitology 54, 249-258.
51. MARSH, I. R., SMITH, H. & BRADLEY, M. (1996). Solid-phase polyamine linkers - their utility in synthesis and preparation of directed libraries against trypanothione reductase. Journal of Chemical Society Chemical Communications, 941-942.
52. MARTINEZ, A., ALLEGRA, C. J. & KOVACS, J. A. (1996). Efficacy of epiroprim (Ro11-8958), a new dihydrofolate reductase inhibitor, in the treatment of acute Toxoplasma infection in mice. American Journal of Tropical Medicine and Hygiene 54, 249-252.
53. MESHNICK, S. R., JEFFORD, C. W., POSNER, G. H., AVERY, M. A. & PETERS, W. (1996). Second-generation antimalarial endoperoxides. Parasitology Today 12, 79-82.
54. MOCKENHAUPT, F. P. (1995). Mefloquine resistance in Plasmodium falciparum. Parasitology Today 11, 248-253.
55. MORGAN, U. M., REYNOLDSON, J. A. & THOMPSON, R. C. A. (1993). Activities of several benzimidazoles and tubulin inhibitors against Giardia spp. in vitro. Antimicrobial Agents and Chemotherapy 37, 328-331.
56. MOULIA-PELAT, J. P., NGUYEN, L. N., GLAZIOU, P., CHANTEAU, S., GAY, V. M., MARTIN, P. M. V. & CARTEL, J. L. (1993). Safety trial of single-dose treatments with a combination of ivermectin and diethylcarbamazine in bancroftian filariasis. Tropical Medicine and Parasitology 44, 79-82.
57. MURPHY, S., ENGLISH, M., WARUIRU, C., MWANGI, I., AMUKOYE, E., CRAWLEY, J., NEWTON, C., WINSTANLEY, P., PESHU, N. & MARSH, K. (1996). An open randomized trial of artemether versus quinine in the treatment of cerebral malaria in African children. Transactions of the Royal Society of Tropical Medicine and Hygiene 90, 298-301.
58. NAVIA, M. A. & CHATURVEDI, P. R. (1996). Design principles for orally bioavailable drugs. Drug Discovery Today 1, 179-189.
59. NAVIN, T. R., ARANA, B. A., ARANA, F. E., HERMAN, J. D. & CHAJÓN, J. F. (1992). Placebo-controlled clinical trial of sodium stibogluconate (Pentostam) versus ketoconazole for treating cutaneous leishmaniasis in Guatemala. Journal of Infectious Diseases 165, 528-534.
60. NÈGRE, E., CHANCE, M. L., HANBOULA, S. Y., MONSIGNY, M., ROCHE, A-C., MAYER, R. M. & HOMMEL, M. (1992). Antileishmanial drug targeting through glycosylated polymers specifically internalized by macrophage membrane lectins. Antimicrobial Agents and Chemotherapy 36, 2228-2232.
61. OLLIARO, P. L. & BRYCESON, A. D. M. (1993). Practical progress and new drugs for changing patterns of leishmaniasis. Parasitology Today 9, 323-328.
62. OLLIARO, P. L. & TRIGG, P. I. (1995). Status of antimalarial drugs under development. Bulletin of the World Health Organisation 73, 565-571.
63. OMURA, S. (1986). Philosophy of new drug discovery. Microbiological Reviews 50, 259-279.
64. OTSYULA, M., KAMAR, K., MUTUGI, M. & NJOGU, A. R. (1992). Preliminary efficacy trial of cymolarsen, a novel trypanocide, in camels naturally infected with Trypanosoma evansi in Kenya. Acta Tropica 50, 271-273.
65. OTTESEN, E. A. & CAMPBELL, W. C. (1994). Ivermectin in human medicine. Journal of Antimicrobial Chemotherapy 34, 195-203.
66. PÉPIN, J. & MILORD, F. (1994). The treatment of human African trypanosomiasis. Advances in Parasitology 33, 2-47.
67. PEREGRINE, A. S. (1994). Chemotherapy and delivery systems: haemoparasites. Veterinary Parasitology 54, 223-248.
68. PETERS, W. (1987). Chemotherapy and Drug Resistance in Malaria. Volume 1. London: Academic Press Limited.
69. RABINOVITCH, M. (1989). Leishmanicidal activity of amino acid and peptide esters. Parasitology Today 5, 299-301.
70. RICHARDS, F. O. JR., KOVACS, J. A. & LUFT, B. J. (1995). Preventing toxoplasmic encephalitis in persons infected with human immunodeficiency virus. Clinical Injections Diseases 21, S49-56.
71. RIECKMANN, K. H., YEO, A. E. T. & EDSTEIN, M. D. (1996). Activity of PS-15 and its metabolite, WR99210, against Plasmodium falciparum in an in vivo-in vitro model. Transactions of the Royal Society of Tropical Medicine and Hygiene 90, 568-571.
72. RINGWALD, P., BICKII, J. & BASCO, L. (1996). Randomised trial of pyronaridine versus chloroquine for acute uncomplicated falciparum malaria in Africa. Lancet 347, 24-28.
73. SHERWOOD, J. A., GACHIHI, G. S., MUIGAI, R. K., SKILLMAN, D. R., MUGO, M., RASHID, J. R., WASUNNA, K. M. A., WERE, J. B. O., KASILI, S. K., MBUGUA, J. M., KIRIGI, G., SCHAEFER, K. U., OSTER, C. N., FLECKENSTEIN, L. L., BERMAN, J. D., BREWER, T. G., ROBERTS, C. R., JOHNSON, A. J. & SCHUSTER, B. G. (1994). Phase 2 efficacy trial of an oral 8-aminoquinoline (WR6026) for treatment of visceral leishmaniasis. Clinical Infectious Diseases 19, 1034-1039.
74. SHU-HUA, X. & CATTO, B. (1989). Comparative in vitro and in vivo activity of racemic praziquantel and its levorotated isomer on Schistosoma mansoni. Journal of Infectious Diseases 159, 589-592.
75. SNEADER, W. (1985). Drug Discovery : The Evolution of Modern Medicines. Chichester, John Wiley & Sons, Ltd.
76. SOMO-MOYOU, R., MITTELHOLZER, M. L., SORENSEN, F., HALLER, L. & STURCHLER, D. (1994). Efficacy of Ro 42-1611 (arteflene) in the treatment of patients with mild malaria: a clinical trial in the Cameroon. Tropical and Medical Parasitology 45, 289-291.
77. SUNDAR, S., ROSENKAIMER, F. & MURRAY, H. W. (1994). Successful treatment of refractory visceral leishmaniasis in India using antimony plus interferon-γ. Journal of Infectious Diseases 170, 659-662.
78. TAELMAN, H., CLERINX, J., BOGAERTS, J. & VERVOORT, T. (1996). Combination treatment with suramin and eflornithine in late stage rhodesian trypanosomiasis: a case report. Transactions of the Royal Society of Tropical Medicine and Hygiene 90, 572-573.
79. TOWNSEND, L. B. & WISE, D. S. (1990). The synthesis and chemistry of certain anthelmintic benzimidazoles. Parasitology Today 6, 107-112.
80. TOWNSON, S. M., BOREHAM, P. F. L., UPCROFT, P. & UPCROFT, J. A. (1994). Resistance to the nitroheterocyclic drugs. Acta Tropica 56, 173-194.
81. TULKENS, P. M. (1991). Intracellular distribution and activity of antibiotics. European Journal of Clinical Microbiology and Infectious Diseases 10, 100-106.
82. VAN DER VEN, A. J. A. M., VREE, T. B., KOOPMANS, P. P. & VAN DER MEER, J. W. M. (1995). Adverse reactions to co-trimoxazole in HIV infection: a reappraisal of the glutathione-hydroxylamine hypothesis. Journal of Antimicrobial Chemotherapy 37, 55-60.
83. VIAL, H. (1996). Recent developments and rationale towards new strategies for malarial chemotherapy. Parasite 3, 3-23.
84. WANG, C. C. (1984). Parasite enzymes as potential targets for antiparasite chemotherapy. Journal of Medicinal Chemistry 27, 1-9.
85. WEBBE, G. (1994). Human cysticercosis: parasitology, pathology, clinical manifestations and available treatment. Pharmacology and Therapeutics 64, 175-200.
86. WERNSDORFER, W. H. (1994). Epidemiology of drug resistance in malaria. Acta Tropica 56, 143-156.
87. WHITE, A. C. JR., CHAPPELL, C. L., HAYAT, C. S., KIMBALL, K. T., FLANIGAN, T. P. & GOODGAME, R. W. (1994). Paromomycin for cryptosporidiosis in AIDS: a prospective, double-blind trial. The Journal of Infectious Diseases 170, 419-424.
88. WHITE, N.J. (1994). Artemisinin: current status. Transactions of the Royal Society of Tropical Medicine and Hygiene 88 (Suppl. 1), 3-4.
89. WORLD HEALTH ORGANIZATION (1995). WHO model prescribing information - Drugs used in parasitic diseases. Geneva, WHO.